Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)
Standard
Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting). / Bruno, Benedetto; Auner, Holger W; Gahrton, Gösta; Garderet, Laurent; Festuccia, Moreno; Ladetto, Marco; Lemoli, Roberto M; Massaia, Massimo; Morris, Curly; Palumbo, Antonio; Schönland, Stefan; Boccadoro, Mario; Kröger, Nicolaus.
In: LEUKEMIA LYMPHOMA, Vol. 57, No. 6, 06.01.2016, p. 1256-1268.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)
AU - Bruno, Benedetto
AU - Auner, Holger W
AU - Gahrton, Gösta
AU - Garderet, Laurent
AU - Festuccia, Moreno
AU - Ladetto, Marco
AU - Lemoli, Roberto M
AU - Massaia, Massimo
AU - Morris, Curly
AU - Palumbo, Antonio
AU - Schönland, Stefan
AU - Boccadoro, Mario
AU - Kröger, Nicolaus
PY - 2016/1/6
Y1 - 2016/1/6
N2 - The European Society for Blood and Marrow Transplantation Chronic Malignancies Working Party held a preceptorship meeting in Turin, Italy on 25-26 September 2014, to discuss the role of stem cell transplantation (SCT) in the treatment of multiple myeloma and other plasma cell disorders. Scientists and clinicians working in the field gathered to discuss a variety of topics including the results of recent clinical trials, basic research, the concept of minimal residual disease, and immune modulation. As individual presentations revealed, important advances have occurred in our understanding of the pathophysiology of myeloma and the role that SCT, along with other forms of immunotherapy, plays in treating it. Each presentation stimulated discussion and exchange of ideas among the attendants. We decided to summarize and, importantly, to update the meeting proceedings in this review to share stimulating discussions and ideas on potentially novel treatment strategies among clinicians.
AB - The European Society for Blood and Marrow Transplantation Chronic Malignancies Working Party held a preceptorship meeting in Turin, Italy on 25-26 September 2014, to discuss the role of stem cell transplantation (SCT) in the treatment of multiple myeloma and other plasma cell disorders. Scientists and clinicians working in the field gathered to discuss a variety of topics including the results of recent clinical trials, basic research, the concept of minimal residual disease, and immune modulation. As individual presentations revealed, important advances have occurred in our understanding of the pathophysiology of myeloma and the role that SCT, along with other forms of immunotherapy, plays in treating it. Each presentation stimulated discussion and exchange of ideas among the attendants. We decided to summarize and, importantly, to update the meeting proceedings in this review to share stimulating discussions and ideas on potentially novel treatment strategies among clinicians.
U2 - 10.3109/10428194.2015.1131278
DO - 10.3109/10428194.2015.1131278
M3 - SCORING: Journal article
C2 - 26735310
VL - 57
SP - 1256
EP - 1268
JO - LEUKEMIA LYMPHOMA
JF - LEUKEMIA LYMPHOMA
SN - 1042-8194
IS - 6
ER -